Leidos awards Pfenex subcontract for development of anthrax vaccine Pfenex announced that Leidos has awarded Pfenex a subcontract in support of the development of an anthrax vaccine containing its recombinant protective antigen and a novel, immune-enhancing adjuvant. The contract was awarded to Leidos by the National Institute of Allergy and Infectious Diseases to improve the efficacy of both anthrax and West Nile virus vaccines by formulating them with a novel adjuvant that stimulates immune responses. Under the subcontract with Leidos, Pfenex will provide its rPA, which will be evaluated in various formulations with a selected adjuvant to optimize the breadth and longevity of immune responses generated against anthrax.
News For LDOS From The Last 14 Days
Check below for free stories on LDOS the last two weeks.